Perfused rat hindquarter preparations were shown to incorporate radioactivity from [U-14C]methionine into citrate-cycle intermediates, lactate, alanine, glutamate, glutamine and CO2. During perfusion, large amounts of methionine were also oxidized to methionine sulphoxide. The capacity for transamination of methionine or its oxo analogue, 4-methylthio-2-oxobutyrate, by muscle extracts was demonstrated. Rat skeletal muscle, heart, liver and kidney mitochondria, when incubated with the latter plus radiolabelled carnitine, formed a newly identified carnitine derivative, 3-methylthiopropionylcarnitine. It is concluded that the capaci-ty for oxidation of methionine by a trans-sulphuration-independent pathway occurs in several mammalian tissues. The extent of inter-organ handling of intermediates in this pathway(s) is discussed.
INTRODUCTION
A series of studies evaluating the ability of skeletal muscle to metabolize amino acids resulted in balance studies which indicated that, of the non-dispensable amino acids, not only the branched-chain amino acids were broken down, but methionine was as well [1, 2] . Methionine is generally assumed not to be metabolized by muscle since the enzymes of the accepted catabolic pathway, the trans-sulphuration-trans-methylation pathway, are very weak, if not totally absent [3, 4] . In recent years Benevenga and co-workers have championed the existence (studied in liver only) of an alternative pathway involving an initial transamination (see, e.g., [5] for review and earlier references). A trans-sulphurationindependent pathway of methionine metabolism is not mentioned in modern biochemistry texts, and is therefore largely ignored. The importance, or even existence, of such a pathway is met by some reviewers with scepticism [6, 7] . However, for the present authors, evidence for the physiological importance of an alternate pathway of methionine catabolism (at least in liver) involving transamination and oxidative decarboxylation is compelling. This evidence is lucidly summarized by Livesey [8] .
In the present study we show that a rat skeletal-muscle preparation converts methionine carbon into citratecycle intermediates, lactate, glutamate, alanine and CO2. In addition, we report that incubation of 'oxomethionine' (4-methylthio-2-oxobutyrate) together with carnitine and mitochondria from four different rat tissues results in formation of 3-methylthiopropionylcarnitine. Hence it appears that 3-methylthiopropionyl-CoA is an intermediate in the breakdown of methionine in at least several tissues.
EXPERIMENTAL Perfusions and metabolite separation
Hindquarters from 48 h-starved male Wistar rats (200-250 g) were perfused for 2 h without added substrate as previously reported [1] . L-[U-14C]Methionine (9 x 106_ 12 x 106 d.p.m.; 300 mCi/mmol) was added to the perfusate after an initial 'washout' of 50 ml. Recovery of total radioactivity in acid-soluble fractions from tissue plus perfusate after 120 min was 56 + 9 %, showing that a substantial portion of endogenous methionine was oxidized to CO2 (see ref. [2] ). Acid-soluble extracts of tissue and perfusate were prepared as in [9] . Separation of amino acids from organic acids, followed by analysis of some organic acids, was as described [10] I To whom reprint requests should be addressed.
Vol. 247 Measurement of transaminase activities in skeletal muscle Extracts were obtained by homogenizing leg muscle in 3 vol. of 50 mM-potassium phosphate/2 mM-EDTA/ 0.5 % Triton X-100 adjusted to pH 7.4. The homogenates were centrifuged at 12000g for 10 min, and the pellet was resuspended and homogenized in the original volume. The supernatant fractions were pooled and used for enzymic assays. Assays for 'glutamine transaminases', types L and K, were carried out as described by Cooper & Meister [11] , and asparagine transaminase was assayed as described by Cooper [12] . Experiments with mitochondria
Mitochondria from heart and kidney [13] , liver [14] and skeletal muscle [15] Heart mitochondria were incubated for 15 min (30°C) with (-)-[methyl-3H]carnitine (1 mM) and oxomethionine (4 mM) as described in the text. After deproteinization and neutralization, 10 mg of synthetic methylthiopropionylcarnitine was added to the sample. The sample was chromatographed on a Dowex 50 column (HI form) eluted with 0.2 M-ammonium formate, pH 4.2; 250,ul portions of each 8 ml fraction were counted for radioactivity. A 2 ml portion of every second fraction between fractions 91 and 119 was freeze-dried, and methylthiopropionylcarnitine was assayed by the hydroxamate reaction at 540 nm. I, Acetylcarnitine; II, carnitine; III, methylthiopropionylcarnitine. In the inset, the upper and lower curves are absorbance (hydroxamate reaction) and radioactivity respectively.
Identification of product metyltloproplonylcarnitine as reaction
Extracts from incubations with carnitine and 4-methylthio-2-oxobutyrate with heart mitochondria were pooled, and approx. 10mg of synthetic methylthiopropionylcarnitine was added. The sample was chromatographed on a Dowex 50 column (0.8 cm x 30 cm) eluted with 0.2 M-ammonium formate (pH 4.2). The samples collected were 8 ml each. Radioactivity was measured in 250,1 samples. A 2 ml portion of each fraction was freeze-dried, and methylthiopropionylcarnitine was assayed by the hydroxamate reaction [16] . Fig. 1 shows that the synthetic derivative exactly co-chromatographs with one of the radioactive peaks.
Exact co-chromatography of the added carrier and the radioactive peak with the highest RF value was also found in the silica-gel t.l.c. system (Fig. 2) .
The fractions from the Dowex column with positive hydroxamate reaction were freeze-dried. The residue was dissolved in 1 M-KOH and hydrolysed at 80°C for 10 min. After acidification with HCI (to pH 1), the sample was extracted with 3 x 1 ml of diethyl ether, methylated with diazomethane [17] and chromatographed on a Pye Unicam gas-liquid chromatograph (GCV chromatograph) equipped with a glass column [1.83 m (6 ft)] filled with 8 % butanediol succinate on Chromosorb WAW (Supelco). The oven temperature was 160 'C. The flame ionization detector was connected to an integrator (Hewlett-Packard 3385A automation system). The gas chromatogram showed one main peak with the same retention time as the original methylthiopropionic acid. Materials
Male albino rats (approx. 200 g) starved overnight were used. Methyl iodide, 3-thiopropionic acid and RESULTS AND DISCUSSION Table 1 shows the distribution of radioactivity derived from trace [U-14C]methionine into some organic and amino acids after perfusion of rat hindquarters for 2 h. About 12% of total remaining radioactivity was recovered as organic acids, and the remainder as amino acids. Of the organic acids, about 35 % of radioactivity recovered was found in lactate plus the citrate-cycle intermediates which were identified. Hence methionine carbon enters the citrate cycle. Some of this carbon, in turn, leaves the cycle by decarboxylation, since radioactivity was recovered in both lactate and alanine (Table   Vol. 247 1). A surprising result was that a large percentage of the amino acid fraction was identified as methionine sulphoxide. The possibility that this conversion was due simply to autoxidation was excluded. Circulation of the perfusates without the hindquarters for 2 h did not lead to formation of methionine sulphoxide. The mechanism of formation of methionine sulphoxide and of its disposition is a subject of continuing studies. Transaminase activities of skeletal muscle
The perfusion studies reported here and in balance studies [1, 2] established that methionine is catabolized. Owing to the virtual absence of the trans-sulphuration pathway we sought other routes of methionine catabolism. As shown in Table 2 , the oxo analogue of methionine is a substrate for both the so-called glutamine transaminase types K and L, by using the definitions and assay conditions of Cooper & Meister [11] . It is of interest that the sulphoxide and sulphone of oxomethionine were also transaminated under the type-K assay conditions. It was shown many years ago [19] that liver contains enzymes capable of transaminating with asparagine. On purification of the enzyme [12] , the original nomenclature of 'asparagine transaminase' was retained. Cooper [12] showed, however, that the purified enzyme has a broad range of specificity toward both oxo acids and amino acids, including methionine. Using the assay conditions of Cooper [12] , we were able to demonstrate detectable, but extremely low, activity with respect to methionine in muscle extracts. Also transamination with pyruvate or 2-oxoglutarate was very weak. Metabolism of oxomethionine and oxoisoleucine by mitochondria Since significant transamination with methionine was demonstrable with muscle extracts, we questioned if and how oxomethionine could be further degraded. The trans-sulphuration-independent pathway of methionine catabolism in liver homogenates involves 3-methylthiopropionic acid as an intermediate [20] . Although the CoA ester of this acid has not been identified, its existence seemed to us likely. Dixon & Benevenga [21] had previously shown that oxomethionine is decarboxylated by liver mitochondria.
In previous studies we identified carnitine esters as intermediates in the catabolism of branched-chain amino acids by perfused hearts [22] and skeletal muscle [23] , thereby demonstrating their metabolism and the formation of CoA esters. We chose to use a similar strategy for methionine metabolism. Oxoisoleucine was chosen as a control, as its metabolism to carnitine intermediates has been demonstrated. At the outset, liver mitochondria were chosen as a control tissue source, since, in view of published work, we could predict that methylthiopropionylcarnitine formation from oxomethionine would be detected.
The data in Table 3 summarize the results of three representative experiments in which skeletal muscle, heart, liver and/or kidney mitochondria were incubated with (-)-[3Hlcarnitine and with no substrate, oxoisoleucine or oxomethionine. After the incubations, the neutralized extracts were chromatographed on t.l.c.
plates, and carnitine and its acyl dernvatives were identified (see the Experimental section). Without added substrate, only acetylcarnitine was formed. With oxo- isoleucine, propionyl-and 2-methylbutyryl-carnitines were formed, as expected from previous studies with perfused muscle and heart [22, 23] . But now, with oxomethionine as substrate, a carnitine ester not previously identified was formed by mitochondria from all four tissues. As outlined in the Experimental section, this carnitine intermediate was identified as 3-methylthiopropionylcarnitine in two chromatographic systems. In a few experiments (as exemplified in Table 3 , Expt. 2) incubations were with a lower carnitine concentration (50 /,M instead of 1 mm, but with 20-fold higher specific radioactivity), resulting in an elevated labelling of propionyl-and 2-methylbutyryl-carnitines (from oxoisoleucine) and of methylthiopropionylcarnitine (from oxomethionine). The higher labelling of acylcarnitines with the low carnitine concentration is probably due to two opposing effects: with lower carnitine concentration, one would expect (by mass action) a lower amount of acylcarnitines: and, since the specific radioactivity of the carnitine in this case was elevated 20-fold, the radioactivity in acylcarnitines would be elevated. Our present and recently published [1, 2] work clearly demonstrates that skeletal muscle metabolizes methionine. It further shows that at least four rat tissues are capable of metabolizing methionine (at least partially) by a trans-sulphuration-independent pathway, with 3-methylthiopropionyl-CoA as an intermediate. [24] showed that, with isolated liver cells, 14C-labelled oxomethionine could form methionine by transamination, and was oxidatively decarboxylated; (c) 3-methylthiopropionate is a product of methionine metabolism by liver homogenates [20] ; and (d) since the present work with mitochondria was completed, Jones & Yeaman [25] reported that oxomethionine is a good substrate for highly purified bovine kidney branchedchain oxo acid dehydrogenase. The metabolism of 3-methylthiopropionate appears to be almost exclusively an hepatic process, on the basis of studies with homogenates of rat tissues [25] . However, this result can be interpreted in two ways. Considering data in references cited, and the present work, free 3-methylpropionate appears to be on a side path of methionine metabolism resulting from deacylation of its CoA ester, as appears to be the case with intermediates in the catabolism of isoleucine and leucine (see ref. [2] ). The first possibility, then, is that the enzyme responsible for re-activation of this acid is present exclusively in the liver. In this case the results of Steele & Benevenga [26] could be interpreted incorrectly, since our present results show that mitochondria from at least three other tissues form its carnitine (and therefore CoA) ester. The second possibility is that enzymes carrying out subsequent steps in the catabolism of 3-methylthiopropionyl-CoA are absent from extra-hepatic tissues, which would probably result in release ofthe free acid and subsequent processing taking place in the liver. A prototype for inter-organ disposition of amino acids is that of valine, and probably of isoleucine and leucine as well [2, 27] . Livesey [8] made the important point that it is a paradox that methionine catabolism (via the accepted trans-sulphuration-transmethylation pathway) should be compulsorily linked to and constrained by transmethylation (anabolic) reactions, and he also recognized an alternative degradative pathway as a conceptual necessity. The present work emphasizes the need for further studies on the interorgan metabolism of methionine by trans-sulphurationindependent pathways.
Since this paper was submitted, an abstract has appeared [28] in which methylthiopropionyl-CoA is Vol. 247 identified as an intermediate in the metabolism of radiolabelled oxomethionine or methylthiopropionate by pig heart mitochondria. These and our results are confirmatory. In addition, our results show that this pathway, at least up to the CoA ester, exists also in several extra-hepatic tissues.
